Table 1: Patient characteristics.
|
|
Omentectomy (N = 27) |
No Omentectomy (N = 21) |
P Value |
|
Mean Age (years) |
70.6 |
70.7 |
0.99 |
|
Mean BMI (Kg/m2) |
32.3 |
31.2 |
0.63 |
|
Mean Length of Stay |
2.07 |
1.57 |
0.51 |
|
Preop/Intraop Grade |
|
|
1.00 |
|
1 |
0 (0%) |
0 (0%) |
|
|
2 |
1 (3.7%) |
1 (4.8%) |
|
|
3 |
26 (96.3%) |
20 (95.2%) |
|
|
Preop/Intraop Histology |
|
|
< 0.0001 |
|
EAC5 |
3 (11.1%) |
19 (90.5%) |
< 0.0001 |
|
USC6 |
16 (59.3%) |
1 (4.8%) |
< 0.0001 |
|
CCC7 |
2 (7.4%) |
1 (4.8%) |
1.00 |
|
MMMT8 |
4 (14.8%) |
0 (0%) |
0.12 |
|
Mixed |
2 (7.4%) |
0 (0%) |
0.50 |
|
CT scan1 |
|
|
1 |
|
Positive |
0 (0%) |
0 (0%) |
|
|
Negative |
25 (100%) |
21 (100%) |
|
|
CA 125 Level N (%) |
|
|
1.00 |
|
CA 125 > 35 N (%) |
5 (23.8%)2 |
3 (18.8%)3 |
|
|
CA 125 ≤ 35 N (%) |
16 (76.2%)2 |
13 (81.3%)3 |
|
|
Adjuvant Treatment |
|
|
0.68 |
|
Treatment |
22 (81.5%) |
18 (90%)4 |
|
|
No Treatment |
5 (18.5%) |
2 (10%) |
|
|
Survival |
|
|
|
|
NED |
17 (63%) |
16 (76.2%) |
0.37 |
|
Recurrence |
7 (25.9%) |
4 (19%) |
0.73 |
|
Death |
3 (11.1%) |
1 (4.8%) |
0.62 |
1Two patients in the omentectomy group did not receive a CT scan; 2CA-125 information was not available for five omentectomy patients; 3CA-125 information was not available for six no omentectomy patients; 4Adjuvant treatment information was not available for one patient; 5Endoemtrioid adenocarcinoma; 6Uterine serous cancer; 7MesodermalMixed Mullerian tumor (carcinosarcoma)